The Clinical and Radiographic Importance of Distinguishing Partial from Near-Complete Reperfusion Following Intra-Arterial Stroke Therapy

References

1. 1.↵
   1. Furlan A,
   2. Higashida R,
   3. Wechsler L,
   4. et al

   . Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial—Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
2. 2.↵
   1. del Zoppo GJ,
   2. Higashida RT,
   3. Furlan AJ,
   4. et al

   . PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke—PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4–11

   Abstract/FREE Full Text
3. 3.↵
   1. Flint AC,
   2. Duckwiler GR,
   3. Budzik RF,
   4. et al

   . Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007;38:1274–80

   Abstract/FREE Full Text
4. 4.↵
   Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761–68

   Abstract/FREE Full Text
5. 5.↵
   1. Ogawa A,
   2. Mori E,
   3. Minematsu K,
   4. et al

   . Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633–39

   Abstract/FREE Full Text
6. 6.↵
   1. Nogueira RG,
   2. Liebeskind DS,
   3. Sung G,
   4. et al

   . Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009;40:3777–83

   Abstract/FREE Full Text
7. 7.↵
   1. Higashida RT,
   2. Furlan AJ,
   3. Roberts H,
   4. et al

   . Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–137

   Abstract/FREE Full Text
8. 8.↵
   1. Kasner SE,
   2. Cucchiara BL,
   3. McGarvey ML,
   4. et al

   . Modified National Institutes of Health Stroke Scale can be estimated from medical records. Stroke 2003;34:568–70

   Abstract/FREE Full Text
9. 9.↵
   1. Berger C,
   2. Fiorelli M,
   3. Steiner T,
   4. et al

   . Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330–35

   Abstract/FREE Full Text
10. 10.↵
    1. Fiorelli M,
    2. Bastianello S,
    3. von Kummer R,
    4. et al

    . Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999;30:2280–84

    Abstract/FREE Full Text
11. 11.↵
    1. Hacke W,
    2. Kaste M,
    3. Fieschi C,
    4. et al

    . Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–25

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Tomsick T,
    2. Broderick J,
    3. Carrozella J,
    4. et al

    . Revascularization results in the Interventional Management of Stroke II Trial. AJNR Am J Neuroradiol 2008;29:582–87

    Abstract/FREE Full Text
13. 13.↵
    1. Arnold M,
    2. Nedeltchev K,
    3. Remonda L,
    4. et al

    . Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J Neurol Neurosurg Psychiatry 2005;76:1373–76

    Abstract/FREE Full Text
14. 14.↵
    1. Fields JD,
    2. Lutsep HL,
    3. Smith WS

    . Higher degrees of recanalization after mechanical thrombectomy for acute stroke are associated with improved outcome and decreased mortality: pooled analysis of the MERCI and Multi MERCI Trials. AJNR Am J Neuroradiol 2011;32:2170–74

    Abstract/FREE Full Text
15. 15.↵
    1. Yoo AJ,
    2. Verduzco LA,
    3. Schaefer PW,
    4. et al

    . MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009;40:2046–54

    Abstract/FREE Full Text
16. 16.↵
    1. Parsons MW,
    2. Christensen S,
    3. McElduff P,
    4. et al

    . Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010;30:1214–25

    CrossRefPubMed
17. 17.↵
    1. Albers GW,
    2. Thijs VN,
    3. Wechsler L,
    4. et al

    . Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508–17

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Shaltoni HM,
    2. Albright KC,
    3. Gonzales NR,
    4. et al

    . Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007;38:80–84

    Abstract/FREE Full Text
19. 19.↵
    1. Tomsick T

    . TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol 2007;28:382–84

    FREE Full Text
20. 20.
    1. Smith WS,
    2. Sung G,
    3. Saver J,
    4. et al

    . Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205–12

    Abstract/FREE Full Text
21. 21.
    1. Lewandowski CA,
    2. Frankel M,
    3. Tomsick TA,
    4. et al

    . Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598–605

    Abstract/FREE Full Text
22. 22.
    IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127–35

    Abstract/FREE Full Text